Medikaloka Hermina (Indonesia) Price Prediction

HEAL Stock  IDR 1,470  85.00  6.14%   
As of now, the value of RSI of Medikaloka Hermina's share price is approaching 34. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Medikaloka Hermina, making its price go up or down.

Oversold Vs Overbought

34

 
Oversold
 
Overbought
The successful prediction of Medikaloka Hermina's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Medikaloka Hermina PT, which may create opportunities for some arbitrage if properly timed.
Using Medikaloka Hermina hype-based prediction, you can estimate the value of Medikaloka Hermina PT from the perspective of Medikaloka Hermina response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medikaloka Hermina to buy its stock at a price that has no basis in reality. In that case, they are not buying Medikaloka because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Medikaloka Hermina after-hype prediction price

    
  IDR 1470.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Medikaloka Hermina Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
1,2171,2191,617
Details

Medikaloka Hermina After-Hype Price Prediction Density Analysis

As far as predicting the price of Medikaloka Hermina at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medikaloka Hermina or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medikaloka Hermina, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Medikaloka Hermina Estimiated After-Hype Price Volatility

In the context of predicting Medikaloka Hermina's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medikaloka Hermina's historical news coverage. Medikaloka Hermina's after-hype downside and upside margins for the prediction period are 1,468 and 1,472, respectively. We have considered Medikaloka Hermina's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1,470
1,470
After-hype Price
1,472
Upside
Medikaloka Hermina is very steady at this time. Analysis and calculation of next after-hype price of Medikaloka Hermina is based on 3 months time horizon.

Medikaloka Hermina Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Medikaloka Hermina is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medikaloka Hermina backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medikaloka Hermina, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.22 
2.00
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1,470
1,470
0.00 
0.00  
Notes

Medikaloka Hermina Hype Timeline

Medikaloka Hermina is currently traded for 1,470on Jakarta Exchange of Indonesia. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Medikaloka is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.22%. %. The volatility of related hype on Medikaloka Hermina is about 0.0%, with the expected price after the next announcement by competition of 1,470. About 51.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 32.62. Medikaloka Hermina last dividend was issued on the 7th of June 2022. The entity had 5:1 split on the 30th of July 2021. Assuming the 90 days trading horizon the next forecasted press release will be in a few days.
Check out Medikaloka Hermina Basic Forecasting Models to cross-verify your projections.

Medikaloka Hermina Related Hype Analysis

Having access to credible news sources related to Medikaloka Hermina's direct competition is more important than ever and may enhance your ability to predict Medikaloka Hermina's future price movements. Getting to know how Medikaloka Hermina's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medikaloka Hermina may potentially react to the hype associated with one of its peers.

Medikaloka Hermina Additional Predictive Modules

Most predictive techniques to examine Medikaloka price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medikaloka using various technical indicators. When you analyze Medikaloka charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Medikaloka Hermina Predictive Indicators

The successful prediction of Medikaloka Hermina stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medikaloka Hermina PT, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medikaloka Hermina based on analysis of Medikaloka Hermina hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medikaloka Hermina's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medikaloka Hermina's related companies.

Story Coverage note for Medikaloka Hermina

The number of cover stories for Medikaloka Hermina depends on current market conditions and Medikaloka Hermina's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medikaloka Hermina is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medikaloka Hermina's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Medikaloka Hermina Short Properties

Medikaloka Hermina's future price predictability will typically decrease when Medikaloka Hermina's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Medikaloka Hermina PT often depends not only on the future outlook of the potential Medikaloka Hermina's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medikaloka Hermina's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding14.7 B
Cash And Short Term Investments1.3 T

Other Information on Investing in Medikaloka Stock

Medikaloka Hermina financial ratios help investors to determine whether Medikaloka Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medikaloka with respect to the benefits of owning Medikaloka Hermina security.